Tamarly Intelligence
Company · DXCM (Nasdaq)

Dexcom Inc

Surgical & Medical Instruments & Apparatus

Key figures
Revenue, 2025
$4.66B
Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Institutional holders
971 at 30 Jun 2026 (962 the quarter before)
SEC number
1093557
LEI
549300YSK3QDSFR5EU59

Source: SEC EDGAR filings and company facts, SEC Form 13F; checked 27 Oct 2026

About

Dexcom Inc is a company that develops, manufactures and distributes continuous glucose monitoring systems, headquartered in San Diego, founded in 1999.

Source: Wikidata

Latest filings
14 Sept 2026
8-K 8-K
10 Sept 2026
8-K 8-K
30 Jul 2026
10-Q 10-Q
30 Jul 2026
8-K 8-K
28 May 2026
8-K 8-K

Source: SEC EDGAR

With a free account

A free account opens 10 full pages a month and lets you follow this page: 12 quarters of figures, every filing and document, earnings call transcripts, holders and ownership changes, the Brain's cards and graph, exports to Excel.

Start freeSign in

Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.